Trial Stopped After Niacin Brings No Benefit to Heart Patients
NIH terminated study 18 months early, citing no drop in heart attacks, strokes for usersContinue Reading
NIH terminated study 18 months early, citing no drop in heart attacks, strokes for usersContinue Reading
Zytiga lengthened survival to nearly 15 months, vs. about 11 months for men on placebo, study saysContinue Reading
Much of this information has more to do with avoiding lawsuits than toxicity, researcher saysContinue Reading
Low cost, better adherence are pluses, but side effects could be problem, experts sayContinue Reading
Vaccines have reduced disease rate in young but death rate remains unchangedContinue Reading
‘Legal highs,’ containing controlled substances, provide booming business for online retailersContinue Reading
As many as 1 million Americans may take the antidepressant and statin together, researchers sayContinue Reading
More testing may reveal helpful role for drug alternative, others sayContinue Reading
Schools urged to do more to prevent drug company influence on prescribing practicesContinue Reading
But researchers found fewer were prescribed when doctors educated parents during visitsContinue Reading
Ob/gyn group says they’re OK for treating urinary tract infections if no other alternativeContinue Reading
Inhaled drugs such as Spiriva, Atrovent may raise odds for urinary retention, study findsContinue Reading
Among people who haven’t received or responded to standard interferonContinue Reading
Incivek cleared body of the liver-damaging virus faster than older meds in trialsContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.